Gutwin 550 Tablet contains Rifaximin 550 mg, a broad-spectrum, non-absorbable antibiotic primarily indicated for the treatment of gastrointestinal infections caused by susceptible bacteria. Rifaximin acts by inhibiting bacterial RNA synthesis, thereby exerting a bactericidal effect within the gastrointestinal tract. It is commonly prescribed for conditions such as travelers’ diarrhea caused by non-invasive strains of Escherichia coli, hepatic encephalopathy to reduce the risk of recurrent episodes by decreasing intestinal ammonia-producing bacteria, and irritable bowel syndrome with diarrhea (IBS-D) to alleviate symptoms. Due to its minimal systemic absorption, Gutwin 550 offers targeted antimicrobial activity with a reduced risk of systemic side effects. The usual dosage and duration depend on the specific indication and patient condition, and it is essential to follow the prescribing physician’s instructions. Gutwin 550 is generally well tolerated; however, adverse effects may include nausea, abdominal pain, and headache. It is contraindicated in patients with known hypersensitivity to rifaximin or any component of the formulation. Caution is advised in patients with severe liver impairment. Gutwin 550 should be used judiciously to minimize the development of bacterial resistance. Always consult a healthcare professional before initiating therapy.